Total Payments
$29,238
2022 Payments
$276.56
Companies
39
Transactions
429
Medicare Patients
649
Medicare Billing
$37,023
Payment Breakdown by Category
Research$20,040 (68.5%)
Food & Beverage$8,744 (29.9%)
Gifts$432.00 (1.5%)
Education$22.34 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $20,040 | 4 | 68.5% |
| Food and Beverage | $8,744 | 421 | 29.9% |
| Gift | $432.00 | 1 | 1.5% |
| Education | $22.34 | 3 | 0.1% |
Payments by Type
Research
$20,040
4 transactions
General
$9,198
425 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20,094 | 21 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $2,259 | 46 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,280 | 68 | $0 (2021) |
| Novo Nordisk Inc | $1,124 | 73 | $0 (2022) |
| Amgen Inc. | $520.67 | 28 | $0 (2022) |
| Allergan, Inc. | $491.97 | 9 | $0 (2020) |
| PFIZER INC. | $393.83 | 26 | $0 (2022) |
| Lilly USA, LLC | $331.88 | 21 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $292.34 | 17 | $0 (2020) |
| Boehringer Ingelheim b.v. | $292.02 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $276.56 | 14 | Novo Nordisk Inc ($102.53) |
| 2021 | $502.72 | 28 | AbbVie Inc. ($92.01) |
| 2020 | $794.58 | 41 | Janssen Pharmaceuticals, Inc ($171.98) |
| 2019 | $1,703 | 78 | Janssen Pharmaceuticals, Inc ($436.79) |
| 2018 | $7,681 | 133 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,802) |
| 2017 | $18,280 | 135 | Boehringer Ingelheim Pharmaceuticals, Inc. ($15,159) |
All Payment Transactions
429 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/14/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Inflammation | ||||||
| 05/27/2022 | Acerus Pharmaceuticals Corporation | Natesto (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Urology Endocrinology Men's Health | ||||||
| 04/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Cardio-renal | ||||||
| 04/04/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Diabetes | ||||||
| 03/30/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: VACCINE | ||||||
| 03/24/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/23/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/10/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Diabetes | ||||||
| 03/09/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Cardio-renal | ||||||
| 02/17/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Diabetes | ||||||
| 02/09/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Diabetes | ||||||
| 02/03/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Cardio-renal | ||||||
| 01/20/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Diabetes | ||||||
| 01/14/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Cardiovascular | ||||||
| 12/15/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Cardiovascular | ||||||
| 11/03/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Diabetes | ||||||
| 09/30/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: VACCINES | ||||||
| 09/22/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Diabetes | ||||||
| 09/01/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Cardiovascular | ||||||
| 08/26/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: VACCINE | ||||||
| 08/25/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Neuroscience | ||||||
| 08/13/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Cardio-renal | ||||||
| 08/04/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| safety and efficacy linagliptin vs SU | Boehringer Ingelheim Pharmaceuticals, Inc. | $19,748 | 2 |
| safety and efficacy linagliptin vs SU | Boehringer Ingelheim b.v. | $292.02 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 110 | 120 | $12,220 | $8,916 |
| 2021 | 5 | 235 | 293 | $21,775 | $15,638 |
| 2020 | 7 | 304 | 353 | $35,277 | $12,469 |
Total Patients
649
Total Services
766
Medicare Billing
$37,023
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 41 | 41 | $6,150 | $5,551 | 90.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 48 | $5,760 | $3,272 | 56.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 28 | 31 | $310.00 | $92.70 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 59 | 59 | $8,850 | $8,118 | 91.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 68 | 92 | $11,040 | $6,617 | 59.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 23 | 23 | $805.00 | $578.42 | 71.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 74 | 108 | $1,080 | $324.00 | 30.0% |
| 91300 | Sarscov2 vac 30mcg/0.3ml im | Office | 2021 | 11 | 11 | $0.11 | $0.11 | 100.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 31 | 31 | $7,575 | $3,670 | 48.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 52 | 57 | $8,581 | $2,756 | 32.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 42 | 45 | $10,091 | $2,699 | 26.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 33 | 35 | $3,090 | $1,152 | 37.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 47 | 56 | $2,800 | $1,062 | 37.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 13 | $1,400 | $786.48 | 56.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 86 | 116 | $1,740 | $342.48 | 19.7% |
About Dr. Alan Graff, MD
Dr. Alan Graff, MD is a Internal Medicine healthcare provider based in Fort Lauderdale, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1669471090.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Graff, MD has received a total of $29,238 in payments from pharmaceutical and medical device companies, with $276.56 received in 2022. These payments were reported across 429 transactions from 39 companies. The most common payment nature is "" ($20,040).
As a Medicare-enrolled provider, Graff has provided services to 649 Medicare beneficiaries, totaling 766 services with total Medicare billing of $37,023. Data is available for 3 years (2020–2022), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Fort Lauderdale, FL
- Active Since 07/18/2005
- Last Updated 08/30/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1669471090
Products in Payments
- TRADJENTA (Drug) $20,055
- XARELTO (Drug) $1,148
- INVOKANA (Drug) $1,100
- FARXIGA (Drug) $722.76
- Ozempic (Drug) $438.84
- Victoza (Drug) $312.70
- Prolia (Biological) $277.75
- SYMBICORT (Drug) $254.92
- ENTRESTO (Drug) $252.51
- CHANTIX (Drug) $247.06
- TRULICITY (Drug) $236.69
- Tresiba (Drug) $220.95
- Vascepa (Drug) $191.85
- BYDUREON (Drug) $177.63
- JARDIANCE (Drug) $169.63
- Natesto (Drug) $141.11
- MYRBETRIQ (Drug) $134.53
- SOLIQUA (Drug) $125.41
- FASENRA (Drug) $125.00
- Epclusa (Drug) $124.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fort Lauderdale
Keith Rubin, M.d, M.D
Internal Medicine — Payments: $2.0M
Internal Medicine $2.0M
Michael Sension, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Bernard Garcia, Md, MD
Internal Medicine — Payments: $499,841
Internal Medicine $499,841
Sheetal Sharma, Md, MD
Internal Medicine — Payments: $272,407
Internal Medicine $272,407
Joshua Lenchus, Do, DO
Internal Medicine — Payments: $82,782
Internal Medicine $82,782
Maxine Hamilton, Md, MD
Internal Medicine — Payments: $27,993
Internal Medicine $27,993